All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

The natural history of progressive fibrosing interstitial lung diseases

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F19%3AN0000071" target="_blank" >RIV/00064190:_____/19:N0000071 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.1186/s12931-019-1022-1" target="_blank" >http://dx.doi.org/10.1186/s12931-019-1022-1</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1186/s12931-019-1022-1" target="_blank" >10.1186/s12931-019-1022-1</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    The natural history of progressive fibrosing interstitial lung diseases

  • Original language description

    A proportion of patients with certain types of interstitial lung disease (ILD), including chronic hypersensitivity pneumonitis and ILDs associated with autoimmune diseases, develop a progressive fibrosing phenotype that shows similarities in clinical course to idiopathic pulmonary fibrosis. Irrespective of the clinical diagnosis, these progressive fibrosing ILDs show commonalities in the underlying pathogenetic mechanisms that drive a self-sustaining process of pulmonary fibrosis. The natural history of progressive fibrosing ILDs is characterized by decline in lung function, worsening of symptoms and health-related quality of life, and early mortality. Greater impairment in forced vital capacity or diffusion capacity of the lungs for carbon monoxide, and a greater extent of fibrotic changes on a computed tomography scan, are predictors of mortality in patients with fibrosing ILDs. However, the course of these diseases is heterogenous and cannot accurately be predicted for an individual patient. Data from ongoing clinical trials and patient registries will provide a better understanding of the clinical course and impact of progressive fibrosing ILDs.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30203 - Respiratory systems

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2019

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    RESPIRATORY RESEARCH

  • ISSN

    1465-993X

  • e-ISSN

    1465-9921

  • Volume of the periodical

    20

  • Issue of the periodical within the volume

    03.2019

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    8

  • Pages from-to

    Article Number: 57

  • UT code for WoS article

    000461673500001

  • EID of the result in the Scopus database

    2-s2.0-85063006773